In short. Devices are approved individually and for stated indications; the combination usually is not. Why approval is not a claim about results, and why settings matter.
Key points
- The conditions a device was accepted under include how it is used.
- Where one modality follows another immediately, the second may be delivered to skin that is already heated or reacting, outside those conditions.
- Nothing about the device has changed.
The regulatory position on combined device treatment is simpler than the marketing around it, and it comes down to one sentence: devices are approved individually and for stated indications, and the combination usually has no separate approval. Three consequences follow, and each is routinely blurred in the way a stacked session is described.
Approval of a device is not approval of a combination
A device is approved for stated indications, in stated modes, with settings that form part of what was accepted. That approval attaches to the device and to those indications, not to any use someone devises by putting it together with something else. Two individually approved devices used on one face in one month do not become an approved treatment, because a combination is not a product: no regulator has assessed that pair as a pair, and none has accepted an indication for it.
Approval is not a claim about results
This is the distinction most often merged in advertising. Approval tells you a regulator accepted the device's safety and intended use for an indication. It does not tell you that a result will be good, how long it will last, or how many sessions it will take, and it does not tell you that combining it with something else will achieve more. Those are claims about outcomes, and they are made by whoever is selling the plan rather than by the approval.
Why settings are part of the approval
The conditions a device was accepted under include how it is used. Where one modality follows another immediately, the second may be delivered to skin that is already heated or reacting, outside those conditions. Nothing about the device has changed. What has changed is the state of the tissue the approval assumed.
Indications are stated as findings, not as appearances
In most jurisdictions these devices are indicated for stated skin findings rather than for an appearance, and none is indicated for the claims that sell combination therapy: fewer sessions, faster results, or a shorter recovery. When a plan is justified in that vocabulary, the justification is not coming from the regulatory position. That matters practically, because a claim with no regulatory basis has no evidence base to check it against.
What a patient can take from this
Three things. The phrase approved for combination is worth questioning, because the combination is usually not what was approved. Whether a device is approved is a separate question from whether a particular plan suits your skin, and only the second one is about you. And whether a device is available in your jurisdiction, and under what restrictions, is a question for a regulator rather than for a clinic or for this review.
Seek care if
- Blistering, or skin that is broken or turning white or grey after a session — seek assessment the same day.
- Pain that is worsening rather than settling, or swelling that increases after the first two days.
- Fever, spreading redness or discharge from a treated area.
Frequently asked questions
Is a combination of two devices approved as a treatment?
Usually not. Devices are approved individually, for stated indications, in stated modes, with settings that form part of what was accepted. Two approved devices used on the same face do not become an approved treatment, because a combination is not a product and no regulator has assessed that pair as a pair.
Does an approved device mean an approved result?
No. Approval means a regulator accepted the device's safety and intended use for a stated indication. It is not a claim about how a result will look, how long it will last, or how many sessions it will take. Results vary between people, and no regulator approves a result.
Why do treatment settings matter to approval?
Because they are part of what was accepted. A session in which one modality follows another immediately may push the second device outside the conditions it was accepted under, particularly where the skin is already heated or reacting. The device is not unapproved; the conditions are no longer the ones the approval describes.
Risks & Limitations
- More treatment in one session means more thermal injury and a longer recovery, not less.
- Pigment change is the commonest unwanted outcome, and the risk is higher in darker skin.
- Burns and blistering are uncommon but real, and they are the mechanism by which scarring happens.
- No outcome can be guaranteed, and approval of a device is not a claim about results.
When to Seek Care
- Blistering, or skin that is broken, weeping or turning white or grey after a session — seek assessment the same day.
- Pain that is worsening rather than settling, or swelling that increases after the first two days.
- A new area of darkening, lightening or mottling that appears or spreads in the weeks after treatment.
- Fever, spreading redness or discharge from a treated area.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It is an evidence review rather than a booking page, and it does not steer anyone towards treatment. Discuss your own case with a qualified clinician; to ask a question about the content of this review, see Contact & Consultation.